Gene therapy and Biomarker for Diabetes
Biomarkers are useful tools for research into type 1 diabetes (T1D) for a number of purposes, including elucidation of disease pathogenesis, risk prediction, and therapeutic monitoring. Susceptibility genes and islet autoantibodies are currently the most useful biomarkers for T1D risk prediction, progress, opportunities, challenges, and future directions in the development of T1D biomarkers.